Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses (Q37712459)

22 August 2017

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses (English)

1 reference

22 August 2017

0 references

9

David A Hafler

1 reference

22 August 2017

8

Philip L De Jager

1 reference

22 August 2017

Lisa M Maier

1

1 reference

22 August 2017

David E Anderson

2

1 reference

22 August 2017

Christopher A Severson

3

1 reference

22 August 2017

Clare Baecher-Allan

4

1 reference

22 August 2017

Brian Healy

5

1 reference

22 August 2017

David V Liu

6

1 reference

22 August 2017

K Dane Wittrup

7

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

22 August 2017

Journal of Immunology

1 reference

22 August 2017

182

1 reference

22 August 2017

1541-1547

1 reference

22 August 2017

3

1 reference

IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Allelic variant in CTLA4 alters T cell phosphorylation patterns

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Risk alleles for multiple sclerosis identified by a genomewide study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Both integrated and differential regulation of components of the IL-2/IL-2 receptor system

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Tolerance, not immunity, crucially depends on IL-2.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

The soluble interleukin 6 receptor: mechanisms of production and implications in disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Axonal pathology in multiple sclerosis: relationship to neurologic disability

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Jaks and STATs: biological implications

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Engineered interleukin-2 antagonists for the inhibition of regulatory T cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Soluble receptors for cytokines and growth factors: generation and biological function

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

The molecular basis for the generation of the human soluble interleukin 2 receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

The monocyte interleukin-2 receptor light chain: production of cell-associated and soluble interleukin-2 receptor by monocytes

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3992946

Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein

1 September 2018

1 reference

12 December 2020

Elevated levels of soluble interleukin-2 receptors in multiple sclerosis

1 reference

12 December 2020

Increased soluble interleukin-2 receptor levels in the sera of type 1 diabetic patients

1 reference

12 December 2020

Interleukin-2 receptor levels indicating relapse in multiple sclerosis

1 reference

12 December 2020

Prospective serial analysis of interleukin-2 and soluble interleukim-2 receptor in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Serum levels of soluble interleukin-2 receptor alpha (sIL-2Ralpha) as a predictor of outcome in brucellosis

1 reference

12 December 2020

10.4049/JIMMUNOL.182.3.1541

Identifiers

DOI

1 reference

release_hd43o2u5gvgdhmipp3ozk3hzpi

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hd43o2u5gvgdhmipp3ozk3hzpi

24 November 2022

mapped directly with Wikidata item

1 reference

22 August 2017

1 reference